PRL logo

Pierrel S.p.A. Stock Price

BIT:PRL Community·€95.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PRL Share Price Performance

€0
0.00 (0.00%)
€0
0.00 (0.00%)
Price €0

PRL Community Narratives

There are no narratives available yet.

Snowflake Analysis

Proven track record with mediocre balance sheet.

3 Risks
1 Reward

Pierrel S.p.A. Key Details

€27.0m

Revenue

€13.4m

Cost of Revenue

€13.6m

Gross Profit

€10.5m

Other Expenses

€3.1m

Earnings

Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
0.057
50.48%
11.53%
109.7%
View Full Analysis

About PRL

Founded
1948
Employees
105
CEO
Fulvio Citaredo
WebsiteView website
www.pierrelgroup.com

Pierrel S.p.A. engages in the development, production, registration, and licensing of synthetic drugs and medical devices for the oral health sector worldwide. It develops and markets dental anesthesia drugs under the Orabloc brand. The company also offers Goccles, a device for screening of the oral cavity. Pierrel S.p.A. was founded in 1948 and is based in Capua, Italy.

Recent PRL News & Updates

Recent updates

No updates

Pierrel S.p.A. Competitors